U.S. Prescription Drug Prices Post Steepest Annual Drop Since 1963
Experts said Medicare negotiations, generic competition and TrumpRx all helped drive the decline, while consumers may not see equal savings.
- The White House credits President Trump's agreements with drug companies and the launch of TrumpRx for the drop, while others point to the 2022 Inflation Reduction Act, signed by former President Joe Biden, which allowed Medicare to negotiate drug prices for the first time.
- Health policy experts say the decline reflects a mix of Republican and Democratic policies along with market pressure, including steep price drops for GLP-1 drugs.
- Some analysts caution that the decline doesn't mean drugmakers are broadly cutting prices, and that sustained reductions will depend on continued implementation across administrations.
78 Articles
78 Articles
![[your]NEWS](/_next/image?url=https%3A%2F%2Fgroundnews.b-cdn.net%2Finterests%2Ffb6dc495f74049f513563c33352175eaa0ecd509.jpg%3Fwidth%3D24&w=64&q=75){kind=small}
U.S. Prescription Drug Prices Post Steepest Annual Decline Since 1963, White House Says
Prescription drug prices have fallen 3.9% since President Donald Trump took office and declined in every month of 2026, with the administration crediting its Most ... The post U.S. Prescription Drug Prices Post Steepest Annual Decline Since 1963, White House Says first appeared on [your]NEWS.
The Daily Caller
What Is Causing US Prescription Drug Costs To Plummet?
Prescription drug prices in the U.S. recently recorded their largest annual drop in several decades.
Drug Prices Plummet by Most Significant Margin in 60 Years in Wake of TrumpRX
Prescription drug prices in the U.S. recently recorded their largest annual decline in several decades, which experts have attributed to a variety of factors. The nation’s prescription drug prices plummeted […] The post Drug Prices Plummet by Most Significant Margin in 60 Years in Wake of TrumpRX appeared first on The Western Journal.
PBS NewsHour
BizTocTrump is taking credit for sharply declining drug prices. The reality is more complex
New federal data that shows U.S. prescription drug prices fell 0.8% in July and are down 3.1% from a year ago, the steepest year-over-year drop since 1963.
Coverage Details
Bias Distribution
- 48% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
